Bridging the gap between in vitro and in vivo evaluation of biomaterial-associated infections

Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies

Volumn 9781461410317, Issue , 2013, Pages 107-117

  Subbiahdoss, Guruprakash ^a   Da Silva Domingues, Joana F ^a   Kuijer, Roel ^a   Van Der Mei, Henny C ^a   Busscher, Henk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; DENTAL PROSTHESES; PROTECTIVE COATINGS;

BACTERIAL ADHESION; BACTERIAL BIOFILM; BIOFILM GROWTH; CLINICAL PROBLEMS; HOST CELLS; IMPLANT SURFACE; IN-VITRO; MAMMALIAN CELLS; VITRO AND IN VIVO; VIVO EVALUATION;

MAMMALS;

EID: 84896544684     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1031-7_5     Document Type: Chapter

References (63)

1. Hebert CK, Williams RE, Levy RS, Barrack RL. Cost of treating an infected total knee replacement. Clin Orthop Relat Res. 1996;331:140-5.
2. Campoccia D, Montanaro L, Arciola CR. The signi ficance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials. 2006;27:2331-9.
3. Trampuz A, Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs. 2005;6:185-90.
4. Calhoun JH, Klemm K, Anger DM, Mader JT. Use of antibiotic-PMMA beads in the ischemic foot. Orthopedics. 1994;17:453-7.
5. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-9.
6. Mohr VD, Eickhoff U, Haaker R, Klammer HL. External fixation of open femoral shaft fractures. J Trauma. 1995;38:648-52.
7. Costerton JW. Bacterial bio films: a common cause of persistent infections. Science. 1999;284:1318-22.
8. Donlan RM, Costerton JW. Bio films: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167-93.
9. Gristina AG, Naylor PT, Myrvik QN. Musculoskeletal infection, microbial adhesion, and antibiotic resistance. Infect Dis Clin North Am. 1990;4:391-408.
10. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237:1588-95.
11. Ahlberg A, Carlsson AS, Lindberg L. Hematogenous infection in total joint replacement. Clin Orthop Relat Res. 1978;137:69-75.
12. Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Airborne contamination of wounds in joint replacement operations: the relationship to sepsis rates. J Hosp Infect. 1983;4:111-31.
13. Fitzgerald RH. Microbiologic environment of the conventional operating-room. Arch Surg. 1979;114:772-5.
14. Verkkala K, Eklund A, Ojajarvi J, Tiittanen L, Hoborn J, Makela P. The conventionally ventilated operating theatre and air contamination control during cardiac surgery-bacteriological and particulate matter control garment options for low level contamination. Eur J Cardiothorac Surg. 1998;14:206-10.
15. Wells CL, Maddaus MA, Simmons RL. Role of the macrophage in the translocation of intestinal bacteria. Arch Surg. 1987;122:48-53.
16. Guo W, Andersson R, Ljungh A, Wang XD, Bengmark S. Enteric bacterial translocation after intraperitoneal implantation of rubber drain pieces. Scand J Gastroenterol. 1993;28:393-400.
17. Okell CC, Elliott CD. Bacteriaemia and oral sepsis with special reference to the etiology of subacute endocarditis. Lancet. 1935;2:869-75.
18. Ohara-Nemoto Y, Haraga H, Kimura S, Nemoto TK. Occurrence of staphylococci in the oral cavities of healthy adults and nasal-oral trafficking of the bacteria. J Med Microbiol. 2008;57:95-9.
19. Gristina AG. Implant failure and the immune-incompetent fibro-inflammatory zone. Clin Orthop Relat Res. 1994;298:106-18.
20. Khalil H, Williams RJ, Stenbeck G, Henderson B, Meghji S, Nair SP. Invasion of bone cells by Staphylococcus epidermidis . Microbes Infect. 2007;9:460-5.
21. Van Delden C, Iglewski BH. Cell-to-cell signalling and Pseudomonas aeruginosa infections. Emerg Infect Dis. 1998;4:551-60.
22. Robinson DA, Enright MC. Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus . Clin Microbiol Infect. 2004;10:92-7.
23. Zimmerli W, Trampuz A, Ochsner PE. Current concepts: prosthetic-joint infections. N Engl J Med. 2004;351:1645-54.
24. Massey RC, Horsburgh MJ, Lina G, Hook M, Recker M. Opinion - the evolution and maintenance of virulence in Staphylococcus aureus : a role for host-to-host transmission? Nat Rev Microbiol. 2006;4:953-8.
25. Mckevitt AI, Bjornson GL, Mauracher CA, Scheifele DW. Amino-acid-sequence of a deltalike toxin from Staphylococcus epidermidis . Infect Immun. 1990;58:1473-5.
26. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis : emerging resistance and need for alternative agents. Clin Infect Dis. 1998;26:1182-7.
27. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002;4:481-9.
28. Ratner BD, Bryant SJ. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng. 2004;6:41-75.
29. Lebaron RG, Athanasiou KA. Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng. 2000;6:85-103.
30. Schuler M, Owen GR, Hamilton DW, De Wilde M, Textor M, Brunette DM, Tosatti SGP. Biomimetic modi fication of titanium dental implant model surfaces using the RGDSP-peptide sequence: a cell morphology study. Biomaterials. 2006;27:4003-15.
31. VandeVondele S, Voros J, Hubbell JA. RGD-Grafted poly- l -lysine-graft-(polyethylene glycol) copolymers block non-speci fic protein adsorption while promoting cell adhesion. Biotechnol Bioeng. 2003;82:784-90.
32. Shi ZL, Neoh KG, Kang ET, Poh C, Wang W. Bacterial adhesion and osteoblast function on titanium with surface-grafted chitosan and immobilized RGD peptide. J Biomed Mater Res A. 2008;86A:865-72.
33. Shi Z, Neoh KG, Kang ET, Poh C, Wang W. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Eng Part A. 2009;15:417-26.
34. Dexter SJ, Pearson RG, Davies MC, Camara M, Shakesheff KM. A comparison of the adhesion of mammalian cells and Staphylococcus epidermidis on fibronectin-modi fied polymer surfaces. J Biomed Mater Res. 2001;56:222-7.
35. Harris LG, Tosatti S, Wieland M, Textor M, Richards RG. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly( l -lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials. 2004;25:4135-48.
36. Maddikeri RR, Tosatti S, Schuler M, Chessari S, Textor M, Richards RG, Harris LG. Reduced medical infection related bacterial strains adhesion on bioactive RGD modi fied titanium surfaces: a first step toward cell selective surfaces. J Biomed Mater Res A. 2008;84A:425-35.
37. Ploux L, Anselme K, Dirani A, Ponche A, Soppera O, Roucoules V. Opposite responses of cells and bacteria to micro/nanopatterned surfaces prepared by pulsed plasma polymerization and UV-irradiation. Langmuir. 2009;25:8161-9.
38. Subbiahdoss G, Kuijer R, Grijpma DW, Van der Mei HC, Busscher HJ. Microbial bio film growth vs. tissue integration: ?the race for the surface? experimentally studied. Acta Biomater. 2009;5:1399-404.
39. Subbiahdoss G, Grijpma DW, Van der Mei HC, Busscher HJ, Kuijer R. Microbial bio film growth vs. tissue integration on biomaterials with different wettabilities and a polymer-brush coating. J Biomed Mater Res A. 2010;94A:533-8.
40. Subbiahdoss G, Saldarriaga Fernández IC, Da Silva Domingues JF, Kuijer R, Van der Mei HC, Busscher HJ. In vitro interactions between bacteria, osteoblast-like cells and macrophages in the pathogenesis of biomaterial-associated infections. PLoS ONE. 2011;6:e0024827.
41. Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br. 1981;63B:342-53.
42. Bennion RS, Williams RA, Wilson SE. Comparison of infectibility of vascular prosthetic materials by quantitation of median infective dose. Surgery. 1984;95:22-6.
43. Fleer A, Verhoef J. New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens. Antonie Van Leeuwenhoek. 1984;50:729-44.
44. Subbiahdoss G, Kuijer R, Busscher HJ, Van der Mei HC. Mammalian cell growth versus bio film formation on biomaterial surfaces in an in vitro post-operative contamination model. Microbiology. 2010;156:3073-8.
45. Anderson JM. Inflammation, wound healing, and the foreign-body response. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials science: an Introduction to materials in medicine. San Diego, CA: Elsevier; 2004. p. 296-304.
46. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 1999;17:593-623.
47. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol. 2002;20:825-52.
48. Stuart LM, Ezekowitz RAB. Phagocytosis: elegant complexity. Immunity. 2005;22:539-50.
49. Boelens JJ, Dankert J, Murk JL, Weening JJ, Van der Poll T, Dingemans KP, Koole L, Laman JD, Zaat SAJ. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis. 2000;181:1337-49.
50. Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood. 1984;64: 959-66.
51. Guenther F, Wabnitz GH, Stroh P, Prior B, Obst U, Samstag Y, Wagner C, Haensch GM. Host defence against Staphylococcus aureus bio films infection: phagocytosis of bio films by polymorphonuclear neutrophils (PMN). Mol Immunol. 2009;46:1805-13.
52. Kaplan SS, Heine RP, Simmons RL. Defensins impair phagocytic killing by neutrophils in biomaterial-related infection. Infect Immun. 1999;67:1640-5.
53. Saldarriaga Fernández IC, Da Silva Domingues JF, Van Kooten TG, Metzger S, Grainger DW, Busscher HJ, Van der Mei HC. Macrophage response to staphylococcal bio film on cross-linked poly(ethylene) glycol polymer coatings in vitro. Eur Cell Mater. 2011;21:73-9.
54. Kubica M, Guzik K, Koziel J, Zarebski M, Richter W, Gajkowska B, Golda A, Maciag-Gudowska A, Brix K, Shaw L, Foster T, Potempa J. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocytederived macrophages. PLoS ONE. 2008;3(1):e1409.
55. Garzoni C, Kelley WL. Staphylococcus aureus : new evidence for intracellular persistence. Trends Microbiol. 2009;17:59-65.
56. Bonventre PF, Imhoff JG. Uptake of 3 H-dihydrostreptomycin by macrophages in culture. Infect Immun. 1970;2:89-95.
57. Tofte RW, Petersoson PK, Kim Y, Quie PG. Influence of serum concentration on opsonization by the classical and alternative complement pathways. Infect Immun. 1980;27:693-6.
58. Watanabe I, Ichiki M, Shiratsuchi A, Nakanishi Y. TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J Immunol. 2007;178:4917-25.
59. Leid JG, Shirtliff HG, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and to respond to Staphylococcus aureus bio films. Infect Immun. 2002;70:6339-45.
60. Johnson GM, Lee DA, Regelmann WE. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun. 1986;54:13-20.
61. Myrvit QN, Wagner W, Barth E, Wood P, Gristina AG. Effects of extracellular slime produced by Staphylococcus epidermidis on oxidative responses of rabbit alveolar macrophages. J Invest Surg. 1989;2:381-9.
62. Shanbhag A, Yang J, Lilien J, Black J. Decreased neutrophil respiratory burst on exposure to cobaltchrome alloy and polystyrene in vitro. J Biomed Mater Res. 1992;26:185-95.
63. Zimmerli W, Waldvogel F. Pathogenesis of foreign body infection. J Clin Invest. 1984;73: 1191-200.